Milestone Pharmaceuticals Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• 07 Aug 2026BTQ Technologies and ITRI Complete Key Milestone in Global QCIM Chip Roadmap Led by BTQ and ICTKPRNewswire

• NBNathalie BeauregardExecutive Officer
• CBCedric BissonDirector
• MBMarco BoorsmaDirector
• EBEla BorensteinDirector
• BCBenjamin CowenExecutive Officer
• PDPhilippe DouvilleDirector · Executive Officer
• DJDominic JaikaranDirector
• NKNilesh KumarDirector
• PLPhilippe LamarreExecutive Officer
• VLVincent LesageExecutive Officer
• DLDebra LiebertDirector
• ELEric LinsleyDirector
• DMDion MadsenDirector
• MMMartin MaguireExecutive Officer
• LMLorenz MullerExecutive Officer
• JNJeff NelsonExecutive Officer
• JOJoseph OlivetoDirector · Executive Officer
• HPHarish PimplaskarExecutive Officer
• FPFrancis PlatExecutive Officer
• YRYves RosconiDirector
• GRGuy RousseauExecutive Officer
• PTPaul TruexDirector · Executive Officer
• SWScott WeinerDirector
• DWDouglas WightExecutive Officer

• 02 Jul 2026Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereofapplication
• 25 Jun 2026Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereofapplication
• 05 Mar 2026Methods Of Administration For Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blockerapplication
• 30 Oct 2025Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereofapplication
• 17 Jul 2025Methods Of Administration For Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blockerapplication
• 19 Jun 2025Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereofapplication
• 25 Mar 2025Methods Of Administration For Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blockergranted
• 20 Mar 2025Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereofapplication
• 07 Nov 2024Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereofapplication
• 22 Aug 2024Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereofapplication
• 11 Apr 2024Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereofapplication
• 28 Dec 2023Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereofapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.